Stem Cell Therapy and Growth Factor Therapy for ALS
Stem Cell Therapy and Growth Factor Therapy for ALS
批准号:
8132268
负责人:
CLIVE Niels SVENDSEN
金额:
$96.01万
依托单位国家:
美国
项目类别:
财政年份:
2007
资助国家:
美国
项目状态:
已结题
起止时间:
2007-09-01 至 2012-03-31
中文摘要
肌萎缩侧索硬化症(ALS)导致运动神经元变性。脊髓腰部运动神经元的丢失会导致肢体瘫痪,而颈部呼吸运动神经元的丢失仍然是疾病进展的决定性时刻,导致呼吸机衰竭和呼吸机依赖。而当
尽管对肌萎缩侧索硬化症发病细胞机制的研究正在产生重要和新颖的见解,但这种方法尚未产生显著改善肌萎缩侧索硬化症患者健康的新药。由于运动神经元死亡的细胞机制可能极其复杂,很难用单一的
对于小分子,我们提出了一种更务实的方法。广泛的长期目标和目的是通过(I)利用内在的可塑性机制,(Ii)提供营养支持或(Iii)使用人类胚胎干细胞(HES)修复运动神经元来保护或恢复运动神经元。为了实现这些目标,有三个目标
高度互动的项目将评估运动神经元功能和在建立良好的ALS大鼠模型中的存活率。项目1将使用解剖学、生理学和行为学的方法来确定ALS大鼠呼吸的准确变化,以及该系统中运动神经元的死亡是否可以通过刺激内源性可塑性来调节。项目2将探索一个
干细胞来源的胶质细胞与GDNF、IGF-1、VEGF、BDNF等营养因子联合应用可减少ALS大鼠运动神经元的死亡,增强其功能。项目3将使用从HES细胞中提取运动神经元的尖端方法,并确定它们是否可以在ALS大鼠的脊髓中存活并与肌肉进行新的接触。关于增长因素各自作用的问题,
星形胶质细胞和运动神经元在运动神经元变性的病理中将在整个项目中不断得到解决。Pi‘s是呼吸神经生物学、人类胚胎干细胞、生长因子和HES细胞领域的知名研究人员。他们将协同工作,分享成果和想法,朝着这笔P01赠款的共同目标迈进。这项研究直接解决了
美国国立卫生研究院:即将获得关于对患者健康产生影响的特定不治之症的基本知识。此外,所采取的许多方法都与治疗策略直接相关,因为干细胞移植是这种毁灭性疾病未来真正的可能性。
英文摘要
Amyotrophic lateral sclerosis (ALS) causes degeneration of motor neurons. Motor neuron loss within lumbar regions of the spinal cord leads to limb paralysis while loss of cervical respiratory motor neurons remains a defining moment in disease progression, leading to ventilatory failure and ventilator dependence. While
investigations of pathogenic cellular mechanisms that underlie ALS are yielding important and novel insights, this approach has not yet produced new drugs that significantly improve the health of ALS patients. Since the cellular mechanisms of motor neuron death may be extremely complex and difficult to block with a single
small molecule, we propose a more pragmatic approach. The broad long term objectives and aims are to protect or restore motor neurons by either (i) harnessing intrinsic mechanisms of plasticity, (ii) providing trophic support or (iii) repacement using human embryonic stem (hES) cells. To achieve these aims, three
highly interactive projects will assess motor neuron function and survival in a well established rat model of ALS. Project 1 will use anatomical, physiological and behavioral approaches to determine the precise changes in respiration that occur in the ALS rat, and whether the death of motor neurons within this system can be modulated through stimulation of endogenous plasticity. Project 2 will explore whether a
combination of stem cell derived glial cells and trophic factors such as GDNF, IGF-1, VEGF and BDNF can reduce motor neuron cell death and enhance function in the ALS rat. Project 3 will use cutting edge methods of deriving motor neurons from hES cells and establish whether they can survive in the ALS rat spinal cord and make new contacts with muscle. Questions regarding the respective roles of growth factors,
astrocytes and motor neurons in the pathology of motor neuron degeneration will be constantly addressed throughout this project. The Pi's are established researchers in their fields of respiratory neurobiology, human fetal stem cells, growth factors and hES cells. They will work synergistically, share results and ideas and move towards the common goals of this P01 grant. This study directly addresses the major goal of the
NIH: i.e. essential knowledge will be gained about a specific incurable disease that will have an impact on the health of patients. Furthermore, many of the approaches taken have direct relevance to treatment strategies as transplantation of stem cells is a real future possibility for this devastating disorder.
期刊论文(7)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
Stem cell biologists sure play a mean pinball.
干细胞生物学家确实玩的是卑鄙的弹球游戏。
DOI:
10.1038/nbt0410-333
发表时间:
2010
期刊:
Nature biotechnology
影响因子:
46.9
作者:
[Sareen,Dhruv, Svendsen,CliveN]
通讯作者:
Svendsen,CliveN
DOI:
10.1371/journal.pone.0007630
发表时间:
2009-10-29
期刊:
PloS one
影响因子:
3.7
作者:
[Sareen D, McMillan E, Ebert AD, Shelley BC, Johnson JA, Meisner LF, Svendsen CN]
通讯作者:
Svendsen CN
DOI:
10.1523/jneurosci.0239-11.2011
发表时间:
2011-05-25
期刊:
The Journal of neuroscience : the official journal of the Society for Neuroscience
影响因子:
--
作者:
[Dale-Nagle EA, Satriotomo I, Mitchell GS]
通讯作者:
Mitchell GS
DOI:
10.1097/wnr.0000000000000092
发表时间:
2014-04-16
期刊:
Neuroreport
影响因子:
1.7
作者:
[Gowing G, Shelley B, Staggenborg K, Hurley A, Avalos P, Victoroff J, Latter J, Garcia L, Svendsen CN]
通讯作者:
Svendsen CN
A Lung-chip microphysiological system to model SARS-CoV-2 infection and test novel therapeutics
-
批准号:10179816
-
项目类别:
-
资助金额:$116.38万
-
财政年份:2020
-
负责人:CLIVE Niels SVENDSEN
-
依托单位:
A microphysiologic multicellular organ-on-chip to inform clinical trials in FTD/ALS
-
批准号:10204148
-
项目类别:
-
资助金额:$80.08万
-
财政年份:2020
-
负责人:CLIVE Niels SVENDSEN
-
依托单位:
A microphysiologic multicellular organ-on-chip to inform clinical trials in FTD/ALS
-
批准号:10515787
-
项目类别:
-
资助金额:$79.22万
-
财政年份:2020
-
负责人:CLIVE Niels SVENDSEN
-
依托单位:
A microphysiologic multicellular organ-on-chip to inform clinical trials in FTD/ALS
-
批准号:10038289
-
项目类别:
-
资助金额:$82.51万
-
财政年份:2020
-
负责人:CLIVE Niels SVENDSEN
-
依托单位:
A microphysiologic multicellular organ-on-chip to inform clinical trials in FTD/ALS
-
批准号:10651873
-
项目类别:
-
资助金额:$70.82万
-
财政年份:2020
-
负责人:CLIVE Niels SVENDSEN
-
依托单位:
Development of a Microphysiological Organ-on-Chip System to Model Amyotrophic
-
批准号:10438517
-
项目类别:
-
资助金额:$117.4万
-
财政年份:2017
-
负责人:CLIVE Niels SVENDSEN
-
依托单位:
Development of a Microphysiological Organ-on-Chip System to Model Amyotrophic
-
批准号:10015354
-
项目类别:
-
资助金额:$121.15万
-
财政年份:2017
-
负责人:CLIVE Niels SVENDSEN
-
依托单位:
A genetic model of inflammatory bowel disease using human intestinal organoids.
-
批准号:9131863
-
项目类别:
-
资助金额:$26.25万
-
财政年份:2015
-
负责人:CLIVE Niels SVENDSEN
-
依托单位:
An iPS Disease-in-a-Dish Model of Familial Alzheimers
-
批准号:8370097
-
项目类别:
-
资助金额:$36.85万
-
财政年份:2012
-
负责人:CLIVE Niels SVENDSEN
-
依托单位:
SHARING IN THE DISCOVERY STEM CELL LEARNING LAB
-
批准号:7958790
-
项目类别:
-
资助金额:$4.68万
-
财政年份:2009
-
负责人:CLIVE Niels SVENDSEN
-
依托单位:
Directing the Fate of Neural Stem Cells with Engineered Gradients of FGF-2
-
批准号:7470911
-
项目类别:
-
资助金额:$19.49万
-
财政年份:2008
-
负责人:CLIVE Niels SVENDSEN
-
依托单位:
SHARING IN THE DISCOVERY STEM CELL LEARNING LAB
-
批准号:7716468
-
项目类别:
-
资助金额:$8.19万
-
财政年份:2008
-
负责人:CLIVE Niels SVENDSEN
-
依托单位:
Stem Cell Therapy and Growth Factor Therapy for ALS
-
批准号:7300366
-
项目类别:
-
资助金额:$117.72万
-
财政年份:2007
-
负责人:CLIVE Niels SVENDSEN
-
依托单位:
Stem Cell Therapy and Growth Factor Therapy for ALS
-
批准号:7596991
-
项目类别:
-
资助金额:$116.63万
-
财政年份:2007
-
负责人:CLIVE Niels SVENDSEN
-
依托单位:
Stem Cell Therapy and Growth Factor Therapy for ALS
-
批准号:7858312
-
项目类别:
-
资助金额:$99.2万
-
财政年份:2007
-
负责人:CLIVE Niels SVENDSEN
-
依托单位:
Stem Cell Therapy and Growth Factor Therapy for ALS
-
批准号:7485149
-
项目类别:
-
资助金额:$114.41万
-
财政年份:2007
-
负责人:CLIVE Niels SVENDSEN
-
依托单位:
DERIVATION OF EMBRYONIC STEM CELLS FOR STUDYING PARKINSON'S DISEASE
-
批准号:7349427
-
项目类别:
-
资助金额:$2.72万
-
财政年份:2006
-
负责人:CLIVE Niels SVENDSEN
-
依托单位:
Stem Cell Research Training Program
-
批准号:7214787
-
项目类别:
-
资助金额:$16.06万
-
财政年份:2005
-
负责人:CLIVE Niels SVENDSEN
-
依托单位:
Stem Cell Research Training Program
-
批准号:6894971
-
项目类别:
-
资助金额:$16.38万
-
财政年份:2005
-
负责人:CLIVE Niels SVENDSEN
-
依托单位:
DERIVATION OF VERVET EMBRYONIC STEM CELLS FOR STUDYING PARKINSON'S DISEASE
-
批准号:7165694
-
项目类别:
-
资助金额:$3.48万
-
财政年份:2005
-
负责人:CLIVE Niels SVENDSEN
-
依托单位:
国内基金
海外基金
登录
查看更多内容
全细胞疫苗Cell@MnO2的乳腺癌术后免疫响应监测与放射免疫治疗研究
-
批准号:QN25H220002
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:顾媛
-
依托单位:
染色体外环状DNA以cell-in-cell途径促进基因横向传递和扩增的研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:15.0万元
-
批准年份:2024
-
负责人:王锐智
-
依托单位:
GMFG/F-actin/cell adhesion 轴驱动 EHT 在造
血干细胞生成中的作用及机制研究
-
批准号:TGY24H080011
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2024
-
负责人:李鸿鹄
-
依托单位:
基于In-cell NMR策略对“舟楫之剂”桔梗中引经药效物质的快速发现研究
-
批准号:82305053
-
项目类别:青年科学基金项目
-
资助金额:30万元
-
批准年份:2023
-
负责人:王丽明
-
依托单位:
面向Cell-Free网络的协同虚拟化与动态传输
-
批准号:62371367
-
项目类别:面上项目
-
资助金额:49万元
-
批准年份:2023
-
负责人:陈健
-
依托单位:
Cell-in-cell促进曲妥珠单抗耐药乳腺癌细胞转移的作用与分子机制
-
批准号:82373069
-
项目类别:面上项目
-
资助金额:49万元
-
批准年份:2023
-
负责人:何美芳
-
依托单位:
基于Multi-Pass Cell的高功率皮秒激光脉冲非线性压缩关键技术研究
-
批准号:--
-
项目类别:青年科学基金项目
-
资助金额:30万元
-
批准年份:2022
-
负责人:宋贾俊
-
依托单位:
基于定点突变膜受体Cell-free合成生物色谱新方法的PDGFRβ抑制剂筛选和结合位点分析
-
批准号:82273886
-
项目类别:面上项目
-
资助金额:52万元
-
批准年份:2022
-
负责人:原永芳
-
依托单位:
FLRT3抑制异质性cell-in-cell结构形成机制及细胞免疫调节作用研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:51万元
-
批准年份:2022
-
负责人:黄红艳
-
依托单位:
基于Cell-SELEX 的磁珠富集技术与LAMP 联合构建的梅毒螺旋体核酸检测方法及其临床应用
-
批准号:2021JJ30609
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2021
-
负责人:肖勇健
-
依托单位: